SAO · DASA3.SA
Diagnósticos da América S.A.
R$3.01+R$0.06 (+2.03%)
Diagnósticos da América S.A.’s quoted price sits in the lower half of its reported 52-week range, 48.01% below the high.
Loading market information…
SAO · PFRM3.SA · BRL
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:53 PM UTC. Cached market data; not a live quote.
One-year closing-price history · BRL. Historical prices are not a forecast.
Profarma Distribuidora de Produtos Farmacêuticos S.A.’s quoted price sits in the lower half of its reported 52-week range, 31.03% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Profarma Distribuidora de Produtos Farmacêuticos S.A.’s forward annual dividend is R$3.82 per share, paid monthly. The forward yield is 57.05% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Profarma Distribuidora de Produtos Farmacêuticos S.A.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1961 and headquartered in Rio de Janeiro, Brazil, Profarma Distribuidora de Produtos Farmacêuticos S.A. is a prominent player in the Brazilian healthcare market, focusing on both the wholesale and retail sales of pharmaceutical and hospital supplies. The company's operations are divided into distinct Distribution and Retail segments. Its comprehensive product offerings include a vast array of pharmaceuticals, such as brand-name drugs, generic alternatives, and over-the-counter medications. Profarma also supplies essential hospital products, including injectable and infusion therapies for specialized medical areas like oncology, endocrinology, rheumatology, infectology, and hematology. Furthermore, it provides specific treatments such as vaccines for conditions like influenza, HPV, meningitis, hepatitis, chickenpox, and dengue, alongside specialized medicines for rare and complex diseases. Beyond pharmaceuticals, the company distributes a wide selection of personal care, beauty, and cosmetic items. This category encompasses shampoos, conditioners, treatment creams, hair dyes, baby products like diapers, soaps, deodorants, oral care essentials, sunscreens, men's grooming products, cosmetics, makeup, and skincare. Profarma also features proprietary lines under the Nº21, GOnutri, and Bem Básico brands, offering exclusive hygiene and beauty products, vitamins, and workshop items. Complementing these, convenience goods such as food products, blood pressure monitors, and scales are also available. The company extends its services to include promotional and logistical support, implementation of marketing campaigns, product recall management, development of bespoke solutions for laboratories, and oversight of clinical procedures.
Latest available per-share figures in BRL. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:17 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
R$3.01+R$0.06 (+2.03%)
Diagnósticos da América S.A.’s quoted price sits in the lower half of its reported 52-week range, 48.01% below the high.
R$9.14-R$0.21 (-2.25%)
Blau Farmacêutica S.A.’s quoted price sits in the lower half of its reported 52-week range, 36.97% below the high.
R$2.51-R$0.05 (-1.95%)
Empreendimentos Pague Menos S.A.’s quoted price sits in the lower half of its reported 52-week range, 67.06% below the high.
R$10.12-R$0.17 (-1.65%)
Dimed S.A. Distribuidora de Medicamentos’s quoted price sits in the lower half of its reported 52-week range, 38.93% below the high.
R$0.77+R$0.06 (+8.45%)
Oncoclínicas do Brasil Serviços Médicos S.A.’s quoted price sits in the lower half of its reported 52-week range, 74.92% below the high.
R$5.38+R$0.03 (+0.56%)
Biomm S.A.’s quoted price sits in the lower half of its reported 52-week range, 44.82% below the high.
R$2.47+R$0.01 (+0.41%)
Allianca Saude e Participacoes S.A.’s quoted price sits in the lower half of its reported 52-week range, 60.1% below the high.
R$1.32+R$0.02 (+1.54%)
Qualicorp Consultoria e Corretora de Seguros S.A.’s quoted price sits in the lower half of its reported 52-week range, 51.65% below the high.
